MARINA BIOTECH INC COM STK (DE)
MRNA
MRNA was delisted on the 1st of February, 2012.
2 hedge funds and large institutions have $42.4K invested in MARINA BIOTECH INC COM STK (DE) in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
48% less capital invested
Capital invested by funds: $82K → $42.4K (-$39.6K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAM
Byrne Asset Management
Kingston,
New Jersey
|
-$37.5K |
MRNA Hedge Fund Activity: Q4 2023 in Review
2 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in MARINA BIOTECH INC COM STK (DE) (MRNA) for Q4 2023, worth a combined $42.4K — down 48% from $82K a quarter earlier.
Fund positioning in MRNA was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Byrne Asset Management, cutting an estimated $37.5K.
- 2 institutional investors held MARINA BIOTECH INC COM STK (DE) (MRNA) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $42.4K of MARINA BIOTECH INC COM STK (DE) stock for Q4 2023, down 48% quarter-over-quarter.
- 0 funds opened new MARINA BIOTECH INC COM STK (DE) positions in Q4 2023 and 0 closed out.
- The largest MARINA BIOTECH INC COM STK (DE) seller in Q4 2023 was Byrne Asset Management, an estimated $37.5K sold.
Based on aggregated 13F filings for Q4 2023.